Humanwell Healthcare (Group) Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Humanwell Healthcare (Group) Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Humanwell Healthcare (Group), the average price target is ¥10.54, with a high estimate of ¥11.81 and a low estimate of ¥9.38. That is a potential downside of approximately -50.68% from the last closing price of ¥21.37 on April, 2024. If you're interested in 600079 stock, looking at its competitors might also be a good idea.
-50.68% Downside
Humanwell Healthcare (Group) Fair Value Forecast for 2023 - 2025 - 2030
Humanwell Healthcare (Group)'s Price has decreased In the last two years, from ¥9.37 to ¥0.00 – a 100.00% drop. The next year looks promising for Humanwell Healthcare (Group), with analysts predicting Fair Value of ¥21.08 – an increase of 100.00%. Over the next seven years, experts anticipate that Humanwell Healthcare (Group)'s Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Outperform |
15
|
¥45.61 | Buy/Sell | ¥56.49 | 18.40% |
| 601607 Stock Forecast | Shanghai Pharmaceuticals Holdi... | Outperform |
18
|
¥17.85 | Buy/Sell | ¥20.67 | 23.25% |
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥60.78 | Buy/Sell | ¥65.95 | 12.11% |
| 600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.19 | Buy/Sell | ¥33.57 | 25.70% |
| 874 Stock Forecast | Guangzhou Baiyunshan Pharmaceu... | Outperform |
16
|
HK$20.95 | Buy/Sell | HK$24.33 | 8.74% |
Humanwell Healthcare (Group) Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Humanwell Healthcare (Group)'s Revenue has grown, increasing from ¥20.68B to ¥24.52B – a growth of 18.59%. The next year looks promising for Humanwell Healthcare (Group), with analysts predicting Revenue of ¥27.04B – an increase of 10.27%. Over the next seven years, experts anticipate that Humanwell Healthcare (Group)'s Revenue will grow at a rate of 10.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
| 600812 Stock Forecast | North China Pharmaceutical Com... | - |
12
|
¥4.91 | Buy/Sell | ¥12.26 | -100.00% |
| 600664 Stock Forecast | Harbin Pharmaceutical Group | - |
11
|
¥2.80 | Buy/Sell | ¥0.00 | -100.00% |
.jpg)
Humanwell Healthcare (Group) Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Humanwell Healthcare (Group)'s Dividend per Share has grown by 360.00%, from ¥0.10 to ¥0.46. According to 2 major analysts, Humanwell Healthcare (Group)'s Dividend per Share will fall by 80.43% in the next year, reaching ¥0.09. Over the next seven years, experts predict that Dividend per Share will grow by 27.19%.
Humanwell Healthcare (Group) EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Humanwell Healthcare (Group)'s EBITDA has grown by 20.55%, rising from ¥3.34B to ¥4.02B. According to 2 analysts, Humanwell Healthcare (Group)'s EBITDA will fall by 5.64% in the next year, reaching ¥3.80B. Over the next seven years, experts predict that Humanwell Healthcare (Group)'s EBITDA will grow at a rate of 33.70%.
Humanwell Healthcare (Group) EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Humanwell Healthcare (Group)'s EBIT has grown by 25.33%, rising from ¥2.66B to ¥3.33B. For next year, analysts predict EBIT of ¥3.63B, which would mean an increase of 9.05%. Over the next seven years, experts predict that Humanwell Healthcare (Group)'s EBIT will grow at a rate of 38.10%.
Humanwell Healthcare (Group) EPS Price Prediction Forecast for 2023 - 2025 - 2030
Humanwell Healthcare (Group)'s EPS has decreased In the last two years, from ¥0.68 to ¥0.00 – a 100.00% drop. The next year looks promising for Humanwell Healthcare (Group), with analysts predicting EPS of ¥1.53 – an increase of 100.00%. Over the next seven years, experts anticipate that Humanwell Healthcare (Group)'s EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)